Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Review Article

A Scoping New Revolution for Tinnitus Management: A Neuromonics Narrative Review

Author(s): Jitendra Gupta* and Reena Gupta

Volume 24, Issue 3, 2023

Published on: 20 January, 2023

Page: [274 - 286] Pages: 13

DOI: 10.2174/1389450124666221220165137

Price: $65

Abstract

With a prevalence ranging from 16-21%, tinnitus is an irking neurological disorder, manifesting as the perception of a roar of cacophony without an external acoustic stimulus. Although tinnitus is a non-life-threatening symptom, tinnitus's negative repercussions, such as personality disturbances and social withdrawal, are daunting concerns despite a gamut of conventional and emerging treatment options. Tinnitus management is still a critical challenge that provides opportunities for clinicians, ENT (Ear/eye, nose and throat) physicians, and other specialists such as audiologists, psychiatrists, and psychologists. Among the new treatment modalities, Neuromonics tinnitus treatment (NTT) draws special attention in tinnitus management due to its mounting success rate. Nonetheless, unlike in developed countries like Australia, the United States, and the United Kingdom, the scanty awareness of NTT among Indian ENT specialists is a titanic setback for care providers. Because of this backdrop, this review emphasized the current perspectives on tinnitus management and the underlying principles and clinical efficacy of NTT. The challenges for tinnitus management can be met and reduced by suppressing tinnitus through motivation, counseling, cochlear implant, and psychotherapy.

Graphical Abstract

[1]
Hoffman HJ, Reed GW. Epidemiology of tinnitus. In: Snow JB, Ed. Tinnitus, theory and management. Lewiston, New York: BC Decker Inc 2004; pp. 16-41.
[2]
Langguth B, Kreuzer PM, Kleinjung T, De Ridder D. Tinnitus: Causes and clinical management. Lancet Neurol 2013; 12(9): 920-30.
[http://dx.doi.org/10.1016/S1474-4422(13)70160-1] [PMID: 23948178]
[3]
Baguley D, McFerran D, Hall D. Tinnitus. Lancet 2013; 382(9904): 1600-7.
[http://dx.doi.org/10.1016/S0140-6736(13)60142-7] [PMID: 23827090]
[4]
Kompis M, Neuner NT, Hemmeler W, Häusler R. Tinnitus. Ther Umsch 2004; 61(1): 15-20.
[http://dx.doi.org/10.1024/0040-5930.61.1.15] [PMID: 14997995]
[5]
Makar SK, Kumar S, Narayanan PS, Chatterjee I. Status of the tinnitus management program in India-A Survey. Int Tinnitus J 2012; 17(1): 51-7.
[PMID: 23906828]
[6]
Meijer AJM, van den Heuvel-Eibrink MM, Brooks B, et al. Society of paediatric oncology supportive care committee. recommendations for age-appropriate testing, timing, and frequency of audiologic monitoring during childhood cancer treatment: An international society of paediatric oncology supportive care consensus report. JAMA Oncol 2021; 7(10): 1550-8.
[http://dx.doi.org/10.1001/jamaoncol.2021.2697] [PMID: 34383016]
[7]
Ren HM, Ren J, Liu W. Recognition and control of the progression of age-related hearing loss. Rejuvenation Res 2013; 16(6): 475-86.
[http://dx.doi.org/10.1089/rej.2013.1435] [PMID: 23915327]
[8]
Langers DRM, Melcher JR. Hearing without listening: Functional connectivity reveals the engagement of multiple nonauditory networks during basic sound processing. Brain Connect 2011; 1(3): 233-44.
[http://dx.doi.org/10.1089/brain.2011.0023] [PMID: 22433051]
[9]
Bauer CA. Mechanisms of tinnitus generation. Curr Opin Otolaryngol Head Neck Surg 2004; 12(5): 413-7.
[http://dx.doi.org/10.1097/01.moo.0000134443.29853.09] [PMID: 15377954]
[10]
Ryan D, Bauer CA. Neuroscience of tinnitus. Neuroimaging Clin N Am 2016; 26(2): 187-96.
[http://dx.doi.org/10.1016/j.nic.2015.12.001] [PMID: 27154602]
[11]
Davis A, Rafaie EA. Epidemiology of tinnitus. In: Tyler RS, Ed. Tinnitus handbook. San Diego, CA: Singular 2000; pp. 1-23.
[12]
Law HK, Corradino MD. Neuropuncture, an effective treatment method for patients with subjective tinnitus accompanied with hearing loss: Case reports. Med Acupunct 2021; 33(4): 295-301.
[http://dx.doi.org/10.1089/acu.2020.1514] [PMID: 34466181]
[13]
Neuromonics the tinnitus company Available from: http:// neuromonics.com/medical-device-about-us/ (Accessed on: January 4, 2021).
[14]
Soto E, Vega R. Neuropharmacology of vestibular system disorders. Curr Neuropharmacol 2010; 8(1): 26-40.
[http://dx.doi.org/10.2174/157015910790909511] [PMID: 20808544]
[15]
De Ridder D, Vanneste S, Menovsky T, Langguth B. Surgical brain modulation for tinnitus: The past, present and future. J Neurosurg Sci 2012; 56(4): 323-40.
[PMID: 23111293]
[16]
Mao JC, Pace E, Pierozynski P, et al. Blast-induced tinnitus and hearing loss in rats: Behavioral and imaging assays. J Neurotrauma 2012; 29(2): 430-44.
[http://dx.doi.org/10.1089/neu.2011.1934] [PMID: 21933015]
[17]
Jastreboff PJ. Phantom auditory perception (tinnitus): Mechanisms of generation and perception. Neurosci Res 1990; 8(4): 221-54.
[http://dx.doi.org/10.1016/0168-0102(90)90031-9] [PMID: 2175858]
[18]
Galazyuk AV, Wenstrup JJ, Hamid MA. Tinnitus and underlying brain mechanisms. Curr Opin Otolaryngol Head Neck Surg 2012; 20(5): 409-15.
[http://dx.doi.org/10.1097/MOO.0b013e3283577b81] [PMID: 22931904]
[19]
Laureano MR, Onishi ET, Bressan RA, et al. Memory networks in tinnitus: A functional brain image study. PLoS One 2014; 9(2): e87839.
[http://dx.doi.org/10.1371/journal.pone.0087839] [PMID: 24516567]
[20]
Makar SK, Jalvi RR, Sinha AK. Study of nature and gender differences of a group of persons suffering from tinnitus. J All India Insti Speech Hear 2009; 28: 164-70.
[21]
De Ridder D, Song JJ, Vanneste S. Frontal cortex TMS for tinnitus. Brain Stimul 2013; 6(3): 355-62.
[http://dx.doi.org/10.1016/j.brs.2012.07.002] [PMID: 22853891]
[22]
Adjamian P, Hall DA, Palmer AR, Allan TW, Langers DRM. Neuroanatomical abnormalities in chronic tinnitus in the human brain. Neurosci Biobehav Rev 2014; 45(100): 119-33.
[http://dx.doi.org/10.1016/j.neubiorev.2014.05.013] [PMID: 24892904]
[23]
Eggermont JJ. Central tinnitus. Auris Nasus Larynx 2003; 30 (Suppl.): 7-12.
[http://dx.doi.org/10.1016/S0385-8146(02)00122-0] [PMID: 12543153]
[24]
Pienkowski M, Eggermont JJ. Cortical tonotopic map plasticity and behavior. Neurosci Biobehav Rev 2011; 35(10): 2117-28.
[http://dx.doi.org/10.1016/j.neubiorev.2011.02.002] [PMID: 21315757]
[25]
Eggermont JJ. Cortical tonotopic map reorganization and its implications for treatment of tinnitus. Acta Otolaryngol 2006; 126(sup556): 9-12.
[http://dx.doi.org/10.1080/03655230600895259] [PMID: 17114136]
[26]
Saïd MB, Hmani-Aifa M, Amar I, et al. High frequency of the p.R34X mutation in the TMC1 gene associated with nonsyndromic hearing loss is due to founder effects. Genet Test Mol Biomarkers 2010; 14(3): 307-11.
[http://dx.doi.org/10.1089/gtmb.2009.0174] [PMID: 20373850]
[27]
Lee AC, Godfrey DA. Cochlear damage affects neurotransmitter chemistry in the central auditory system. Front Neurol 2014; 5(227): 227.
[http://dx.doi.org/10.3389/fneur.2014.00227] [PMID: 25477858]
[28]
Rauschecker JP, Leaver AM, Mühlau M. Tuning out the noise: Limbic-auditory interactions in tinnitus. Neuron 2010; 66(6): 819-26.
[http://dx.doi.org/10.1016/j.neuron.2010.04.032] [PMID: 20620868]
[29]
Richardson BD, Brozoski TJ, Ling LL, Caspary DM. Targeting inhibitory neurotransmission in tinnitus. Brain Res 2012; 1485: 77-87.
[http://dx.doi.org/10.1016/j.brainres.2012.02.014] [PMID: 22405692]
[30]
Chung JH, Lee SH. The pathophysiologic mechanism of tinnitus. Hanyang Med Rev 2016; 36(2): 81-5.
[31]
Neuromonics The Tinnitus Company. Available from: monicsprofessional.com/wpcontent/uploads/2010/12/CL11-00002-Rev-2-Oasis-Tinnitus Treatment-Workbook.pdf (Accessed on: March 13, 2022).
[32]
Colorado Tinnitus and Hearing Center Inc. Available from: https://tinnitusandhearing.com/hearing-and-tinnitus-center-denver-co (Accessed on: March 9, 2022).
[33]
Wilson PH, Henry J, Bowen M, Haralambous G. Tinnitus reaction questionnaire: Psychometric properties of a measure of distress associated with tinnitus. J Speech Lang Hear Res 1991; 34(1): 197-201.
[http://dx.doi.org/10.1044/jshr.3401.197] [PMID: 2008074]
[34]
Jun HJ, Park MK. Cognitive behavioral therapy for tinnitus: Evidence and efficacy. Korean J Audiol 2013; 17(3): 101-4.
[http://dx.doi.org/10.7874/kja.2013.17.3.101] [PMID: 24653916]
[35]
Manche SK, Madhavi J, Meganadh KR, Jyothy A. Association of tinnitus and hearing loss in otological disorders: A decade-long epidemiological study in a South Indian population. Rev Bras Otorrinolaringol (Engl Ed) 2016; 82(6): 643-9.
[PMID: 26923827]
[36]
Hobson J, Chisholm E, El Refaie A. Sound therapy (masking) in the management of tinnitus in adults. Cochrane Libr 2012; 11: CD006371.
[http://dx.doi.org/10.1002/14651858.CD006371.pub3] [PMID: 23152235]
[37]
Yuan H, Wang X, Hill K, et al. Autophagy attenuates noise-induced hearing loss by reducing oxidative stress. Antioxid Redox Signal 2015; 22(15): 1308-24.
[http://dx.doi.org/10.1089/ars.2014.6004] [PMID: 25694169]
[38]
Forti S, Crocetti A, Scotti A, et al. Tinnitus sound therapy with open ear canal hearing aids. B-ENT 2010; 6(3): 195-9.
[PMID: 21090162]
[39]
Valdéz-Hernández A, Ortega-Palacios R, Vázquez-López G, Ramos-Lora N. Transcranial direct current stimulation in psychiatric disorders: A comprehensive review of recent advances. Curr Psychiatry Rev 2019; 14(4): 230-8.
[http://dx.doi.org/10.2174/1573400514666181119114610]
[40]
Meng Z, Liu S, Zheng Y, Phillips JS. Repetitive transcranial magnetic stimulation for tinnitus. Cochrane Database Syst Rev 2011; 5(10): CD007946.
[PMID: 21975776]
[41]
Tabuchi K, Nishimura B, Nakamagoe M, Hayashi K, Nakayama M, Hara A. Ototoxicity: Mechanisms of cochlear impairment and its prevention. Curr Med Chem 2011; 18(31): 4866-71.
[http://dx.doi.org/10.2174/092986711797535254] [PMID: 21919841]
[42]
Aazh H, El Refaie A, Humphriss R. Gabapentin for tinnitus: A systematic review. Am J Audiol 2011; 20(2): 151-8.
[http://dx.doi.org/10.1044/1059-0889(2011/10-0041)] [PMID: 21940981]
[43]
Bilici S, Yigit O, Taskin U, Gor AP, Yilmaz ED. Medium-term results of combined treatment with transcranial magnetic stimulation and antidepressant drug for chronic tinnitus. Eur Arch Otorhinolaryngol 2015; 272(2): 337-43.
[http://dx.doi.org/10.1007/s00405-013-2851-z] [PMID: 24337899]
[44]
Han SS, Nam EC, Won JY, et al. Clonazepam Quiets tinnitus: A randomised crossover study with Ginkgo biloba. J Neurol Neurosurg Psychiatry 2012; 83(8): 821-7.
[http://dx.doi.org/10.1136/jnnp-2012-302273] [PMID: 22626945]
[45]
Kallio H, Niskanen ML, Havia M, Neuvonen PJ, Rosenberg PH, Kentala E. I.V. ropivacaine compared with lidocaine for the treatment of tinnitus. Br J Anaesth 2008; 101(2): 261-5.
[http://dx.doi.org/10.1093/bja/aen137] [PMID: 18522937]
[46]
Gupta JK, Kumar SS, Misra V, Patel K. Evaluation of antinociceptive and anti-inflammatory activity of Punicagranatum seed extract. Int Res J Pharm 2011; 2(12): 235-7.
[47]
Panda SP, Soni U. A review of dementia, focusing on the distinct roles of viral protein corona and MMP9 in dementia: Potential pharmacotherapeutic priorities. Ageing Res Rev 2022; 75: 101560.
[http://dx.doi.org/10.1016/j.arr.2022.101560] [PMID: 35031512]
[48]
Ehrenberger K. Clinical experience with caroverine in inner ear diseases. Adv Otorhinolaryngol 2002; 59: 156-62.
[http://dx.doi.org/10.1159/000059252] [PMID: 11885656]
[49]
Brozoski T, Odintsov B, Bauer C. Gamma-aminobutyric acid and glutamic acid levels in the auditory pathway of rats with chronic tinnitus: A direct determination using high resolution point-resolved proton magnetic resonance spectroscopy (1H-MRS). Front Syst Neurosci 2012; 6(9): 9.
[http://dx.doi.org/10.3389/fnsys.2012.00009] [PMID: 22383901]
[50]
Enrico P, Sirca D, Mereu M. Antioxidants, minerals, vitamins, and herbal remedies in tinnitus therapy. Prog Brain Res 2007; 166: 323-30.
[http://dx.doi.org/10.1016/S0079-6123(07)66029-4] [PMID: 17956795]
[51]
Hilton MP, Zimmermann EF, Hunt WT. Ginkgo biloba for tinnitus. Cochrane Database Syst Rev 2013; 28(3): CD003852.
[PMID: 23543524]
[52]
Drew S, Davies E. Effectiveness of Ginkgo biloba in treating tinnitus: Double blind, placebo controlled trial. BMJ 2001; 322(7278): 73.
[http://dx.doi.org/10.1136/bmj.322.7278.73] [PMID: 11154618]
[53]
House JW, Brackmann DE. Tinnitus: Surgical treatment. Ciba Found Symp 1981; 85: 204-16.
[PMID: 6915835]
[54]
Kim DK, Bae SC, Park KH, et al. Tinnitus in patients with profound hearing loss and the effect of cochlear implantation. Eur Arch Otorhinolaryngol 2013; 270(6): 1803-8.
[http://dx.doi.org/10.1007/s00405-012-2193-2] [PMID: 23053375]
[55]
Cushing SL, Chia R, James AL, Papsin BC, Gordon KA. A test of static and dynamic balance function in children with cochlear implants: The vestibular olympics. Arch Otolaryngol Head Neck Surg 2008; 134(1): 34-8.
[http://dx.doi.org/10.1001/archoto.2007.16] [PMID: 18209133]
[56]
Akil O, Blits B, Lustig LR, Leake PA. Virally mediated overexpression of glial-derived neurotrophic factor elicits age- and dose-dependent neuronal toxicity and hearing loss. Hum Gene Ther 2019; 30(1): 88-105.
[http://dx.doi.org/10.1089/hum.2018.028] [PMID: 30183384]
[57]
Yoo HB, De Ridder D, Vanneste S. White matter changes in tinnitus: Is it all age and hearing loss? Brain Connect 2016; 6(1): 84-93.
[http://dx.doi.org/10.1089/brain.2015.0380] [PMID: 26477359]
[58]
Guitton M. Tinnitus and anxiety: More than meets the ear. Curr Psychiatry Rev 2006; 2(3): 333-8.
[http://dx.doi.org/10.2174/157340006778018139]
[59]
Munjal SK, Panda NK, Pathak A. Dynamics of hearing status in closed head injury. J Neurotrauma 2010; 27(2): 309-16.
[http://dx.doi.org/10.1089/neu.2009.0957] [PMID: 20136520]
[60]
Tan WJT, Song L, Graham M, et al. Novel role of the mitochondrial protein fus1 in protection from premature hearing loss via regulation of oxidative stress and nutrient and energy sensing pathways in the inner ear. Antioxid Redox Signal 2017; 27(8): 489-509.
[http://dx.doi.org/10.1089/ars.2016.6851] [PMID: 28135838]
[61]
Phillips JS, McFerran D. Tinnitus retraining therapy (TRT) for tinnitus. Cochrane Database Syst Rev 2010; 17(3): CD007330.
[PMID: 20238353]
[62]
Molini E, Faralli M, Calzolaro L, Ricci G. Impact of identifying factors which trigger bothersome tinnitus on the treatment outcome in tinnitus retraining therapy. ORL J Otorhinolaryngol Relat Spec 2014; 76(2): 81-8.
[http://dx.doi.org/10.1159/000360994] [PMID: 24777173]
[63]
Zenner HP, Vonthein R, Zenner B, et al. Standardized tinnitus-specific individual cognitive-behavioral therapy: A controlled outcome study with 286 tinnitus patients. Hear Res 2013; 298: 117-25.
[http://dx.doi.org/10.1016/j.heares.2012.11.013] [PMID: 23287811]
[64]
Jansson-Fröjmark M, Linton SJ, Flink IK, Granberg S, Danermark B, Norell-Clarke A. Cognitive-behavioral therapy for insomnia co-morbid with hearing impairment: A randomized controlled trial. J Clin Psychol Med Settings 2012; 19(2): 224-34.
[http://dx.doi.org/10.1007/s10880-011-9275-y] [PMID: 22323041]
[65]
Goyal A, Gupta JK, Garabadu D. Phytoestrogens are emerging medicine in prevention and management of cognitive deficits in postmenopausal women. Res J Pharm Technol 2021; 14(1): 513-5.
[http://dx.doi.org/10.5958/0974-360X.2021.00093.7]
[66]
Henry J, Zaugg T, Myers P, Kendall C, Turbin M. Principles and application of educational counseling used in progressive audiologic tinnitus management. Noise Health 2009; 11(42): 33-48.
[http://dx.doi.org/10.4103/1463-1741.45311] [PMID: 19265252]
[67]
Semwal BC, Verma M, Murti Y, Yadav HN. Neuroprotective activity of Sesbania grandifolara seeds extract against celecoxib induced amnesia in mice. Pharmacogn J 2018; 10(4): 747-52.
[http://dx.doi.org/10.5530/pj.2018.4.125]
[68]
Fioretti A, Eibenstein A, Fusetti M. New trends in tinnitus management. Open Neurol J 2011; 5(1): 12-7.
[http://dx.doi.org/10.2174/1874205X01105010012] [PMID: 21541237]
[69]
Philippot P, Nef F, Clauw L, Romrée M, Segal Z. A randomized controlled trial of mindfulness-based cognitive therapy for treating tinnitus. Clin Psychol Psychother 2012; 19(5): 411-9.
[http://dx.doi.org/10.1002/cpp.756] [PMID: 21567655]
[70]
Zhang M, Zhou H, Zhang J, Guo Y, Wang X, Wang N. Evaluating the effects of hearing aids combined with psychological counseling on tinnitus in patients with deafness. J Clin Otorhinolaryngol Head Neck Surg 2013; 27(10): 461-4.
[PMID: 23937007]
[71]
Nuheara IQbuds Boost Intelligent Wireless Earbuds Hearing Amplifiers. Available from: https://www.amazon. in/Nuheara-Intelligent-Wireless-Earbuds-Amplif iers/dp/B07FX (Accessed on: March 28, 2022).
[72]
[73]
Tinnitus Maskers. Available from: https://www.indiamart.com/city hearingaids/tinnitus-maskers.html (Accessed on: March 28, 2022).
[74]
Sound Comforts. Available from: https://soundcomforts.com/new-delhi/?gclid=Cj0KCQjw06OT (Accessed on: March 28, 2022).
[75]
ENT Audiology News. Available from: ynews.com/industry-news/post/neuromod-launches-lenire-tinnitus-treatment-device-to-tinnitus-suffer (Accessed on March 29, 2022).
[76]
Premier Hearing Center. Available from: http://premierhearing. com/hearing-aids/we-offer-soundcure-serenade/ (Accessed on March 29, 2022).
[77]
Mute Function Call Center USB Headset Noise Cancelling USB Call Center Headset with Microphone. Available from: https://www.amazon.in/Function-Center-Headset-Cancelling-Microphone/dp/B07N (Accessed on: March 29, 2022).
[78]
Levo System Available through U.S. Federal Supply Schedule (FSS). Available from: https://www.prnewswire.com/ news-releases/va-now-covers-cost-of-the-levo-sys tem-for-tinnitus-treatment-300801922.html (Accessed on: March 29, 2022).
[79]
Tinnitus App. Available from: https://www.tinnitusapps.com/tinn itus-apps/widex-zen (Accessed on: March 30, 2022).
[80]
Oticon Hearing Aid. Available from: https://www.indiamart.com /proddetail/oticon-hearing-aid-19508602155.html (Accessed on: March 30, 2022).
[81]
Naturecare sound enrichment device. Available from: ent.org.uk/products/naturecare-sound-enrichment-device-l238 (Accessed on: March 30, 2022).
[82]
Puretone MM10 White Noise Generator. Available from: https:// tinnitushearingsolutions.com/product/all/tinnitus-maskers/mm10/ (Accessed on: March 30, 2022).
[83]
Tinnitus Relief Tag: Sound Pillow. Available from: https:// www.puretone.net/shop/product/sound-pillow/ (Accessed on: March 30, 2022).
[84]
Wazen JJ, Daugherty J, Pinsky K, et al. Evaluation of a customized acoustical stimulus system in the treatment of chronic tinnitus. Otol Neurotol 2011; 32(4): 710-6.
[http://dx.doi.org/10.1097/MAO.0b013e318217d459] [PMID: 21451428]
[85]
Hanley PJ, Davis PB, Paki B, Quinn SA, Bellekom SR. Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: Clinical outcomes in general private practice. Ann Otol Rhinol Laryngol 2008; 117(11): 791-9.
[http://dx.doi.org/10.1177/000348940811701101] [PMID: 19102123]
[86]
Ponticorvo S, Manara R, Pfeuffer J, et al. Long-range auditory functional connectivity in hearing loss and rehabilitation. Brain Connect 2021; 11(6): 483-92.
[http://dx.doi.org/10.1089/brain.2020.0814] [PMID: 33478362]
[87]
Davis PB, Wilde RA, Steed LG, Hanley PJ. Treatment of tinnitus with a customized acoustic neural stimulus: A controlled clinical study. Ear Nose Throat J 2008; 87(6): 330-9.
[http://dx.doi.org/10.1177/014556130808700611] [PMID: 18561116]
[88]
Goddard JC, Berliner K, Luxford WM. Recent experience with the neuromonics tinnitus treatment. Int Tinnitus J 2009; 15(2): 168-73.
[PMID: 20420343]
[89]
Vieira D, Eikelboom R, Ivey G, Miller S. A multi-centre study on the long-term benefits of tinnitus management using Neuromonics Tinnitus Treatment. Int Tinnitus J 2011; 16(2): 111-7.
[PMID: 22249869]
[90]
Jang DW, Johnson E, Chandrasekhar SS. Neuromonics™ Tinnitus Treatment: Preliminary experience in a private practice setting. Laryngoscope 2010; 120(S4) (Suppl. 4): S208.
[http://dx.doi.org/10.1002/lary.21675] [PMID: 21225806]
[91]
Miguel Jesu´s Reyes-Campos, M.J.; Dı´az-Toral, L.G. . How do you treat Tinnitus in your practice? Med Acupunct 2013; 25(5): 365-7.
[http://dx.doi.org/10.1089/acu.2013.2552]
[92]
Seidman MD, Standring RT, Dornhoffer JL. Tinnitus: Current understanding and contemporary management. Curr Opin Otolaryngol Head Neck Surg 2010; 18(5): 363-8.
[http://dx.doi.org/10.1097/MOO.0b013e32833c718d] [PMID: 20625292]
[93]
Abrams H, Chisolm TH, McArdle R. A cost-utility analysis of adult group audiologic rehabilitation: Are the benefits worth the cost? J Rehabil Res Dev 2002; 39(5): 549-58.
[PMID: 17684833]
[94]
Davis PB, Paki B, Hanley PJ. Neuromonics tinnitus treatment: Third clinical trial. Ear Hear 2007; 28(2): 242-59.
[http://dx.doi.org/10.1097/AUD.0b013e3180312619] [PMID: 17496674]
[95]
Han BI, Lee HW, Kim TY, Lim JS, Shin KS. Tinnitus: Characteristics, causes, mechanisms, and treatments. J Clin Neurol 2009; 5(1): 11-9.
[http://dx.doi.org/10.3988/jcn.2009.5.1.11] [PMID: 19513328]
[96]
Távora-Vieira D, Eikelboom RH, Miller S. Neuromonics tinnitus treatment for patients with significant level of hearing loss: An adaptation of the protocol. Int J Audiol 2011; 50(12): 881-6.
[http://dx.doi.org/10.3109/14992027.2011.606286] [PMID: 21936710]
[97]
Newman CW, Sandridge SA. A comparison of benefit and economic value between two sound therapy tinnitus management options. J Am Acad Audiol 2012; 23(2): 126-38.
[http://dx.doi.org/10.3766/jaaa.23.2.7] [PMID: 22353681]
[98]
Smith AK, Jain N, Wallhagen ML. Hearing loss in palliative care. J Palliat Med 2015; 18(6): 559-62.
[http://dx.doi.org/10.1089/jpm.2014.0367] [PMID: 25867966]
[99]
Simoes JP, Daoud E, Shabbir M, et al. Multidisciplinary Tinnitus Research: Challenges and future directions from the perspective of early stage researchers. Front Aging Neurosci 2021; 13: 647285.
[http://dx.doi.org/10.3389/fnagi.2021.647285] [PMID: 34177549]
[100]
Formby C, Scherer R. Rationale for the tinnitus retraining therapy trial. Noise Health 2013; 15(63): 134-42.
[http://dx.doi.org/10.4103/1463-1741.110299] [PMID: 23571304]
[101]
Makar SK, Mukundan G, Gore G. Treatment of tinnitus: A scoping review. Int Tinnitus J 2017; 21(2): 144-56.
[http://dx.doi.org/10.5935/0946-5448.20170027] [PMID: 29336134]
[102]
Dauman N, Erlandsson SI. Learning from tinnitus patients’ narratives-A case study in the psychodynamic approach. Int J Qual Stud Health Well-being 2012; 7(1): 19540.
[http://dx.doi.org/10.3402/qhw.v7i0.19540] [PMID: 23272657]
[103]
Tyler RS, Keiner AJ, Walker K, et al. A series of case studies of tinnitus suppression with mixed background stimuli in a cochlear implant. Am J Audiol 2015; 24(3): 398-410.
[http://dx.doi.org/10.1044/2015_AJA-15-0005] [PMID: 26001407]
[104]
Cobo P. Successful aplication of sound therapy to a patient with severe tinnitus: Case study. J Otolaryngol Head Neck Surg 2021; 7: 51.
[105]
Kutyba J, Jedrzejczak WW, Raj-Koziak D, Gos E, Skarzynski PH. Tinnitus sound therapy with a mobile application: Case study. J Hear Sci 2019; 9(4): 51-6.
[http://dx.doi.org/10.17430/1003717]
[106]
Robert Hearing Clinic. Case studies-tinnitus intervention results. Available from: clinic.com/case-studies (Accessed on: April 5, 2022).
[107]
Students Academy of Audiology. Case study-Active lifestyle and tinnitus Available from: https://saa.audiology.org/case-study-active-lifestyle-and-tinnitus/ (Accessed on: April 5, 2022).
[108]
Winkler PA. Tinnitus treatment. U.S. Patent 20140046230A1, 2014.
[109]
Fan-Gang Z, Qing T, Carroll JC. Devices and methods for suppression of tinnitus. Eur. Patent 2224987A1, 2015.
[110]
Lenhardt ML. Tinnitus masker/suppressor. U.S. Patent 20010051776A1, 2001.
[111]
Melman RO. System and method for tinnitus suppression. WIPO (PCT) WO2020188415A1, 2001.
[112]
Daniel M, Gilles K. Device for treating tinnitus. Eur. Patent 2958342A1, 2015.
[113]
Lim HH, Hamilton M, Guo H, Gloeckner C. Ultrasonic hearing system and related methods. U.S. Patent 10904676B2, 2021.
[114]
Searchfield GD, Kobayashi K, Irving S. Tinnitus treatment system and method. U.S. Patent 20180126115A1, 2018.
[115]
Mailman RO. Systems and methods for tinnitus suppression. Chinese Patent 113194897A, 2021.
[116]
Henry JA, Silaski G, Gray D, Porsov EV, Owens K. Method and apparatus for tinnitus evaluation. U.S. Patent 20130131542A1, 2013.
[117]
Micheyl CD. Method and apparatus for tinnitus evaluation with test sound automatically adjusted for loudness. U.S. Patent 10842418B2, 2020.
[118]
Goorevich M, Khing PP, Killian MJP, Van Dijk B. Tinnitus masking in hearing prostheses. WIPO (PCT) WO2017203396A1, 2017.
[119]
Marek P. Tinnitus fitting method in CI and ABI patients. U.S. Patent 9566435B2, 2017.
[120]
Zeng FG, Djalilian H, Lin H. Tinnitus treatment with precise and optimal electric stimulation. Curr Opin Otolaryngol Head Neck Surg 2015; 23(5): 382-7.
[http://dx.doi.org/10.1097/MOO.0000000000000187] [PMID: 26208122]
[121]
Wenzel GI, Sarnes P, Warnecke A, et al. Non-penetrating round window electrode stimulation for tinnitus therapy followed by cochlear implantation. Eur Arch Otorhinolaryngol 2015; 272(11): 3283-93.
[http://dx.doi.org/10.1007/s00405-014-3413-8] [PMID: 25480476]
[122]
Markovitz CD, Hogan PS, Wesen KA, Lim HH. Pairing broadband noise with cortical stimulation induces extensive suppression of ascending sensory activity. J Neural Eng 2015; 12(2): 026006.
[http://dx.doi.org/10.1088/1741-2560/12/2/026006] [PMID: 25686163]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy